trial

C-Cog in Early Course Schizophrenia Study

NCTId NCT05662306
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Terminated
Enrollment 1 (actual)
Sponsored by University of Miami
Primary completion 2025-03-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Terminated
Enrollment
1 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2024-01-23
Primary completion
2025-03-03
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
AripiprazoleComputerized cognitive and functional skills training

Sponsors

University of MiamiLead Sponsor
Alkermes, Inc.Collaborator

Investigators

1
Dante Durand, MDPrincipal Investigator

Sites

1 total
Miami, United States

Facts & assertions

4 sourced
Enrollment
1
Phase
PHASE4
Primary Completion Date
2025-03-03
Status
TERMINATED
relationships
The graph out of here
drug
Aripiprazole
drug
Computerized cognitive and functional skills training
drug
lead_sponsor
University of Miami
company
collaborator
Alkermes, Inc.
company
indication
Schizophrenia
indication
Schizophrenia
indication
Recurrence
indication
investigator
Dante Durand, MD
person